Overview

Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

1. To assess the clinical and neurophysiological efficacy of Xeomin® vs. Botox® in children with spastic equine and equinovarus foot deformation in pediatric cerebral palsy 2. To assess the safety of Xeomin® use as compared to Botox® in this patient population

Phase:

Phase 2

Details

Lead Sponsor:

Merz Pharmaceuticals GmbH

Collaborator:

LLC Merz Pharma, Russia

Treatments:

abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA